Dr. Hunziker was elected director of Genentech in April 2004. He joined
the Roche Group as chief financial officer in 2001 and was elected to
the Executive Committee of the Roche Group at that time. In January
2005, he was appointed deputy head of the Executive Committee. Prior
to joining the Roche Group, from 1998 until 2001, Dr. Hunziker was
chief executive officer of the Diethelm Group and Diethelm Keller
Holding Ltd. Dr. Hunziker joined...
More
Dr. Hunziker was elected director of Genentech in April 2004. He joined
the Roche Group as chief financial officer in 2001 and was elected to
the Executive Committee of the Roche Group at that time. In January
2005, he was appointed deputy head of the Executive Committee. Prior
to joining the Roche Group, from 1998 until 2001, Dr. Hunziker was
chief executive officer of the Diethelm Group and Diethelm Keller
Holding Ltd. Dr. Hunziker joined Corange Ltd (holding company of
Boehringer Mannheim Group), where he was appointed chief financial
officer in 1997. Dr. Hunziker is also a member of the Boards of
Directors of Holcim Ltd. and Chugai Pharmaceutical Co., Ltd., a
subsidiary of Roche. Pursuant to the affiliation agreement, Dr.
Hunziker is a designee of Roche.
Less
